Intersting thoughts

Search

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
AVDL. 7.80 in after-hours.. A company I've traded unsuccessfully before...but I still them follow loosely.
I've been thinking about the reason they are selling off legacy parts of the company ..profitable units...Last unit sale was July 1st for 42 MILL
A buy out is coming soon IMO . Bio is risky for sure but M@A is about to explode in Bio.
https://seekingalpha.com/news/35877...tal-sterile-injectable-drug-portfolio-for-42m

I've been following a bit of a trail from AVDL to JAZZ (ticker JAZZ) $105.00. AVDL has what JAZZ needs badly.
The existence of JAZZ almost depends on AVDL's narcolepsy drug FT218.
JAZZ isn't afraid to step in mid 3rd phase and pay up/they've done 3rd phase buyouts twice ... AVDL's FT218 is in the 3rd phase and pending approval.

Two ways to play this..I'm try to decide witch one works best..
Buy JAZZ..who's been crushed because 70% of their profits are tied to the soon to be second best narcolepsy drug on the market but minimize getting smoked on a failed trial.Less risk but I'm not interested in getting in to a long hold on JAZZ...
Or Buy AVDL and potentially double your money but open yourself up to a possible crushing with a trial failure.

Lots or rumors tying to two together out there.

Or just blow it off/I've had a couple of horrible experiences with this sort of play before and a couple of homers too.

High risk either way but "interesting"
 

Member
Joined
Apr 30, 2009
Messages
5,008
Tokens
Interesting scenario. Thanks for sharing.
 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
Interesting scenario. Thanks for sharing.

"Scenario" is the key word.
I read the Avadel 1Q 2020 earning call this AM and thought about it a lot last night. AVDL ended up getting Top line Numbers in the 3rd phase study early numbers ...JAZZ has stepped up for two/ 3rd phase companies with top line numbers while also paying top line take out prices....AVDL fits those markers and also fits in the JAZZ portfolio beautifully.

Super risky..I'm going to watch over the next few days..have a call in to an analyst friend who's more in to bio than me to get his opinion.
If you're looking for a low risk cheap playing LLNW below 7.75 even 8 bucks up to earnings on the 20th looks decent with out huge risk or super high risk with a potential pay out..ADVL @ 7.60 before the bell...but as Bruins point out smartly this is just a scenario.

Thanks Smartmoney...I sorta have it rolling finally

Opening bell..good luck fellas
 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
Trying not to fall in love with any of my picks ..except JD ..Sold BZUN just now @44.44..I'll but back once it starts ticking up.. Virtually no competition huge upside.
Crazy as it seems I bought ADVL for 7.71...for the "scenario" play.
They have the goods IMO and JAZZ has no choice..if JAZZ isn't the buyer some will be..No doubt in my mind this company pairing down for a suitor who only wants FT218
The gambler in me rears it head ...I'll only hold this till mid august or even late July ..After reading ADVL the transcript this AM it feels like a short term sell plan despite outward projections you see in every transcript ....

Super high risk!..you could easily lose 70% or quickly make somewhere around 100% with a buyout.

Don't do it.
 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
new-jt-banner-newsletter.png

Global Market Comments
July 10, 2020
Fiat Lux

Featured Trade:
(HOW TO HANDLE THE FRIDAY, JULY 17 OPTIONS EXPIRATION),
(REGN), (ILMN), (SGEN), (JPM)

mti-pos-53.jpg



How to Handle the Friday, July 17 Options Expiration

Followers of the Mad Hedge Fund Trader alert service have the good fortune to own FOUR deep in-the-money options positions that expire on Friday, July 17, and I just want to explain to the newbies how to best maximize their profits.These involve the:

Seattle Genetics (SGEN) 7/140-$145 call spread
Illumina (ILMN) 7/$320-$330 call spread
Regeneron (REGN) 7/$570-$580 call spread
JP Morgan Chase (JPM) 7/$80-$85 call spread
Provided that we don’t have another 3,000-point move down in the market by next week, these positions should expire at their maximum profit points.

So far, so good.

I’ll do the math for you on our oldest and least liquid position which I almost certainly will run into expiration. Your profit can be calculated as follows:

Profit: $5.00 expiration value - $4.30 cost = $0.70 net profit

(23 contracts X 100 contracts per option X $0.70 profit per option)

= $1,610 or 16.27% in 18 trading days.

Many of you have already emailed me asking what to do with these winning positions.

The answer is very simple. You take your left hand, grab your right wrist, pull it behind your neck, and pat yourself on the back for a job well done.

You don’t have to do anything.

Your broker (are they still called that?) will automatically use your long position to cover your short position, canceling out the total holdings.

The entire profit will be credited to your account on Monday morning July 20 and the margin freed up.

Some firms charge you a modest $10 or $15 fee for performing this service.

If you don’t see the cash show up in your account on Monday, get on the blower immediately and find it.

Although the expiration process is now supposed to be fully automated, occasionally machines do make mistakes. Better to sort out any confusion before losses ensue.

If you want to wimp out and close the position before the expiration, it may be expensive to do so. You can probably unload them pennies below their maximum expiration value.

Keep in mind that the liquidity in the options market understandably disappears, and the spreads substantially widen, when a security has only hours, or minutes until expiration on Friday, July 17. So, if you plan to exit, do so well before the final expiration at the Friday market close.

This is known in the trade as the “expiration risk.”

One way or the other, I’m sure you’ll do OK, as long as I am looking over your shoulder, as I will be, always. Think of me as your trading guardian angel.

I am going to hang back and wait for good entry points before jumping back in. It’s all about keeping that “Buy low, sell high” thing going.

I’m looking to cherry-pick my new positions going into the next month-end.

Take your winnings and go out and buy yourself a well-earned dinner. Just make sure it’s take-out. I want you to stick around.

Well done, and on to the next trade.

SGEN-jul10.png
REGN-jul10.png
ILMN-jul10.png
JPM-jul10.png
john-and-girls.png
[h=3]You Can’t Do Enough Research[/h]


Quote of the Day

“The stock market is not expensive at 2% Fed funds and 2% government bonds,” said my old investor and mentor Leon Cooperman of Omega Advisors.
bargains.png







 

Member
Joined
Apr 30, 2009
Messages
5,008
Tokens
Trying not to fall in love with any of my picks ..except JD ..Sold BZUN just now @44.44..I'll but back once it starts ticking up.. Virtually no competition huge upside.
Crazy as it seems I bought ADVL for 7.71...for the "scenario" play.
They have the goods IMO and JAZZ has no choice..if JAZZ isn't the buyer some will be..No doubt in my mind this company pairing down for a suitor who only wants FT218
The gambler in me rears it head ...I'll only hold this till mid august or even late July ..After reading ADVL the transcript this AM it feels like a short term sell plan despite outward projections you see in every transcript ....

Super high risk!..you could easily lose 70% or quickly make somewhere around 100% with a buyout.

Don't do it.

You sound like me when guys ask what horses I like.
I dont ever want to feel responsible for someone else's losses.
 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
You sound like me when guys ask what horses I like.
I dont ever want to feel responsible for someone else's losses.


Yeah..My buddy who owns horses hates having his amateur bettor friends come when his horses run...People who don't bet get too sad when they lose.
I don't want anyone to lose money because of my picks...I like risk so I am a bad person to follow... with that.
I've found a lot I like about this company.
FT218 has patent protection till 2034 and exclusive for the first 7 years....Cash cow if approved.
When you look further in to the recent unit sale it makes absolutely no sense .... It was worth 12 Million a year to the bottom line and they sold it for 42 million to market a drug that hasn't been approved by the FDA..
Hedge funds seem to be loading up..some hedge bought 400+k in the last 30 miniutes of trading today. Up 4% today in the last 1/2 hour of trading.
18 dollar price placed on it this AM by an analyst.


"Jazz Pharmaceuticals’ extremely concentrated $1.7B Xyrem market. Xyrem, we think, is a remarkably successful product, but its middle-of-the-night second dose leaves much to be desired, and high orphan-drug pricing would allow Avadel to achieve considerable sales with modest market penetration. We model FT218 peak $360M U.S. sales. AVDL stock had a remarkable 510% run from its 2019 nadir up to the data (vs. XBI +17%), but has been surprisingly weak since the positive results despite a strong biotech tape. We think investors are skeptical for a range of reasons, all of which we believe are wrong, including: (1) FT218 data appears less robust than Xyrem; (2) Jazz could legally delay or block FT218 launch; (3) the brand oxybate market will be materially eroded with 2023 generic entry; or (4) there is no potential strategic optionality remaining. We think the stock currently undervalues the FT218 opportunity."
 

Member
Joined
Feb 28, 2005
Messages
8,810
Tokens
Where do you think the bottom is on SQQQ? Been a steady decline as people continue to sell off.

I got into SQQQ a few weeks ago....and I'm down 17%. It's killing me. I've added some more as it's dropped. The P&E of the market right now is scary AF. I'm expecting a drop...probably as we get closer to the election. But losing 17% right out of the gate is a kick in the nuts (while everything else has moved up). I know playing market timing is foolish, but this one is bothersome (to put it mildly!).
 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
I got into SQQQ a few weeks ago....and I'm down 17%. It's killing me. I've added some more as it's dropped. The P&E of the market right now is scary AF. I'm expecting a drop...probably as we get closer to the election. But losing 17% right out of the gate is a kick in the nuts (while everything else has moved up). I know playing market timing is foolish, but this one is bothersome (to put it mildly!).


I had it as well and dumped it when I bought LLNW...I lost 15% But it was a small hedge the 3X leverage has to be respected and a little fear isn't bad when leveraged.
IDK..but I think it's hugely important to the administration the stock market keeps floating up till the vote at least.
I wasn't sure how to read what Mnuchin said last week but it felt like another liquidity injection in the near term isn't going to happen.
I do think things will get ugly eventually..I'm in in China pretty big right now and it makes me nervous..in the last few weeks I made up huge ground after sitting out too long on the market....

I've been watching the asian markets at night and getting up at 5:30 to read anything I can get my hands on on the companies I like.
No doubt at some point all these mid caps.. 1 to 3 billion dollar companies will get some love but when is the question.

very strange out there..I'm invested but weary for sure.

Good luck CB
 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
new-jt-banner-newsletter.png

Global Market Comments
July 13, 2020
Fiat Lux

Featured Trade:
(MARKET OUTLOOK FOR THE WEEK AHEAD, or HERE COMES HERD IMMUNITY),
(INDU), (TSLA), (SPY), (GLD), (JPM), (IBB), (QQQ), (AAPL), (MSFT), (DCUE), (NVDA)

mti-pos-53.jpg



The Market Outlook for the Week Ahead, or Here Comes Herd Immunity

The US passed a single-day record of 70,000 new cases for Covid-19 over the weekend, with Florida bringing in an astounding 15,300.
We missed a chance to stop the epidemic in January because we were blind. Then we missed again in April because we were lazy, when New York City was losing nearly 1,000 souls a day and ignored the lessons therein.

So, we relentlessly continue our march towards herd immunity, when two-third of the population gets the disease, protecting the remaining one third. That’s about a year off.

That implies total American deaths will reach 2.2 million, more than we have lost from all our wars combined.


The faster people die, the closer we are to the end of the plague, which is good news for everyone.

And the stock market keeps going up every day, the worse the news, the faster. That may be happening because the more severe the shock to the system, the faster companies must evolve to survive, making them ever more profitable.


Out with the Old America, in with the new. The future is happening fast.

We here at Mad Hedge Fund Trader have just delivered the most astonishing quarter in our 13-year record, up some 41.98% from the March 16 low.

That makes me cautious. Things never stay that good for long. Just because I can’t see the next black swan doesn’t mean it isn’t going to happen.

If stocks rise when corona cases are exploding, what do they do when cases fall? Do they fall too, or do they rise even faster?

That’s above my pay grade. I’m only a captain, not a general.

So, I will be moving to a 100% cash position in coming days and then let the next black swan tell me what to do. If we suffer a severe dive, and 10%-20% is entirely possible, then I’ll jump back in with my “BUY” hat on. That means testing the lower up of my six-month (SPX) 2,700-$3,200 range.

If we suddenly surge to far greater heights and new all-time highs, then I will be selling short as fast as I can write the trade alerts.

In the meantime, we have Q2 earnings to look forward to in the coming week, which will certainly be one for the history books. The bullish view is that they will be down only 44% from a dismal Q1. The bearish view is far worse. Banks (JPM) kick off on Tuesday.

NASDAQ (QQQ) hit a new high at 10,622, with Apple (AAPL) and Microsoft (MSFT) leading the charge. Elon Musk is now looking at another $1.7 billion payday with his shares touching $1,500. I’m moving to 100% cash, peeling off one profitable position a day as each option play reaches its maximum profit. I just had the best quarter in a decade, up an eye-popping 40%, and I’m just not that smart to keep it going. Humility always wins in the long-term.

Goldman Sachs chopped its growth forecast in the face of soaring Covid-19 cases, paring their Q3 prediction from +33% to +25%. Political campaign rallies are spreading the disease faster than expected. Q1 most likely came in at negative -5%. Expect worse to come. If the stock market can’t break at 135,000 corona deaths, it will at 260,000 or 520,000, which is certainly coming.

NVIDIA topped Intel as most valuable chip company. No surprise here. High-end graphics cards are worth a lot more money than plain commodity processors. Keep buying dips on (NVDA) which we’ve been loading the boat with now for four years. There’s an easy double from here.

Warren Buffet bought Dominion Energy (DCUE), in one of the only distressed sales available this year, thanks so much to government support. With natural gas prices at all-time lows, the big boys are throwing in the towel. Immense public pressure is forcing public utilities to abandon fossil fuels. Warren will sell all of his newfound energy in the $10 billion deal to China. It’s the beginning of the end for carbon. Buy (TSLA) on dips.

Dividend Cuts will drive stock trading in H2. Energy, airline, cruise lines, casinos, movie theaters, and hotels are most at risk, while big technology companies like Apple are the safest. Currently, the S&P 500 is yielding 2.0%, while the ten-year US Treasury bond is paying out 0.65%. Room for a cut?

Tesla to reach $100 billion in annual revenue by 2025, says San Francisco-based JMP Securities. The logic goes that if they can produce 90,000 vehicles a quarter during a pandemic, 140,000 a quarter should be no problem by yearend. The news delivered a move in the shares to a new all-time high of $1,549. Inclusion of (TSLA) in the S&P 500 would also deliver a lot of forced institutional buying, which might take the shares up 40% more. The future is happening fast. Keep buying (TSLA) on dips for a 2021 target of $2,500. If this keeps up, we may see it next week. Remember, I traded Tokyo in 1989. Nothing is impossible.

US student visas were canceled in ostensibly an administration coronavirus-fighting measure, but really in the umpteenth measure to shut foreigners out. “America first” is turning into “America only.” Midwestern schools in particular will be hurt by the loss of 400,000 full tuition-paying international students, especially when state education budgets are getting cut to the bone. That’s down from 800,000 three years ago. If they’re already here, how does this help us? Most colleges are moving to online-only models to limit infections.


When we come out the other side of this, we will be perfectly poised to launch into my new American Golden Age, or the next Roaring Twenties. With interest rates still at zero, oil cheap, there will be no reason not to. The Dow Average will rise by 400% or more in the coming decade.

My Global Trading Dispatch enjoyed another blockbuster week, up an astounding +2.28. It was a week when everything worked in the extreme….again.

My eleven-year performance rocketed to a new all-time high of 381.74%. A triple weighting in biotech and a double weighting in gold were a big help. A foray into the banks proved immediately successful. I seem to have the Midas touch these days.

That takes my 2020 YTD return up to an industry-beating +25.83%. This compares to a loss for the Dow Average of -8.8%, up from -37% on March 23. My trailing one-year return popped back up to a record 66.22%, also THE HIGHEST IN THE 13-YEAR HISTORY of the Mad Hedge Fund Trader. My eleven-year average annualized profit recovered to a record +36.07%, another new high.

The only numbers that count for the market are the number of US Coronavirus cases and deaths, which you can find here. It’s jobs week and we should see an onslaught of truly awful numbers.

On Monday, July 13 at 10:00 AM EST, the June Inflation Expectationsare out.

On Tuesday, July 14 at 7:30 AM EST, US Core Inflation for June is published
On Wednesday, July 15, at 7:30 AM EST, US Industrial Production for June is announced. At 10:30 AM EST, the EIA Cushing Crude Oil Stocks are out.
On Thursday, June 16 at 8:30 AM EST, Weekly Jobless Claims are announced. At 7:30 AM, US Retail Sales for June is printed.

On Friday, June 17, at 7:30 AM EST, the US Housing Starts for June are released.

The Baker Hughes Rig Count is out at 2:00 PM EST.

As for me, I am training hard for my upcoming 50-mile hike with the Boy Scouts, knocking off 10 miles a day at 9,000 feet on the Tahoe Rim Trail. I have to confess that I’m feeling the knees like never before.

As they used to say in the Marine Corps, “Pain is fear leaving the body.” More than knowledge comes with age. Pain is there as well.

Marine Corps to Boy Scout leader. It’s been a full life.

Stay healthy.

John Thomas
CEO & Publisher
The Diary of a Mad Hedge Fund Trader


1yr-jul13.png

11yr-jul13.png

compq-jul13.png

spy-jul13.png

jpm-jul13.png

tsla-jul13.png

tlt-jul13.png

john-shirtless.png
[h=2]The Years Have Not Been Kind[/h]​


Quote of the Day

“Send us your freaks,” said an Amazon human resources executive to a temp agency during its early days.
tatto.png







 

Member
Handicapper
Joined
Sep 25, 2005
Messages
4,522
Tokens
Bozzie what do you make of these crazy swings up 550 and then negative 30 minutes to the bell.
 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
Big time consolidation, I'd guess it's going to be a bit more drastic given the past few months.
Tesla lead todays weirdness... I also think a lot of new investors jumped out today.
If you've never traded and have only seen your stock go up...people panic... good thing it was at the end of the session.
Cloud stocks got the shit beaten out of them all day from the get go.... never participated today

Good day to buy? maybe.
What are you thinking?
 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
good read today.

Five Things
Five Things You Need to Know to Start Your Day
By Lorcan Roche Kelly

July 14, 2020, 3:40 AM PDT




[h=2]SHARE THIS ARTICLE[/h]
Share


Tweet


Post


Email


[h=2]In this article[/h]SPX
S&P 500
3,155.22
USD
-29.82-0.94%

WFC
WELLS FARGO & CO
25.41
USD
-0.06-0.24%

TSLA
TESLA INC
1,497.06
USD
-47.59-3.08%

LMT
LOCKHEED MARTIN
353.06
USD
+3.81+1.09%

C
CITIGROUP INC
52.20
USD
-0.45-0.85%






Lockdown policies tighten, U.S.-China tensions rise, and earnings season kicks off.


[h=2]Shutdowns are back[/h]Yesterday's order by California Governor Gavin Newsom that all indoor entertainment, including bars and restaurants, will close spooked markets. In something of a change of tone from the White House, Vice President Mike Pence told U.S. governors that the administration would back them on any measures they take to control the pandemic. The stop-start pace of reopenings is a global phenomenon with Hong Kong tightening rules, Tokyo looking at declaring another state of emergency if the case count continues to rise, and Iran closing schools and religious sites. Conversely, shares in gambling stocks in Asia surged after some Chinese travel restrictions for Macau were lifted.


[h=2]Taking sides[/h]The Trump administration rejected China's expansive claims in the South China Sea, with Secretary of State Michael Pompeo saying they are "completely unlawful." The statement is a reversal of a previous policy of not taking sides in maritime disputes in the region. In another sign of tensions rising between the world's two largest economies, China announced it was imposing sanctions on Lockheed Martin Corp. after the U.S. approved a deal for the supply of missile parts to Taiwan. Relations between the nations have been hit on a number of fronts, including by the security law imposed in Hong Kong, treatment of minorities in Xinjiang, and the pandemic itself.


Sponsor Content by PIMCO

Building Resiliency Amid Uncertainty
Investing in an environment where asset prices seem disconnected and a health crisis persists can be unnerving. Build a portfolio that aims to weather a range of future paths using our latest asset allocation outlook as a guide. Read more.


[h=2]Earnings week[/h]JPMorgan Chase & Co., Citigroup Inc. and Wells Fargo & Co. get Wall Street earnings season started before the bell this morning. The results are expected to be dominated by big provisions for loan losses, with trading revenue likely to be the only silver lining. Investors will likely pay close attention to management commentary as they try to get a handle on what is a very cloudy outlook for the industry.


[h=2]Markets rise[/h]California's shaped virus reality-check delivered just before markets closed in the U.S. yesterday put pressure on investor sentiment across the world. Overnight, the MSCI Asia Pacific Index slipped 0.8% while Japan's Topix index closed 0.5% lower. There were signs some of the air has come out of China's market surge. In Europe the Stoxx 600 Index was down 1.2% at 5:50 a.m. Eastern Time, led by declines in tech and travel shares. S&P 500 futures pointed to a small rebound at the open, the 10-year Treasury yield was at 0.628% and gold was lower.
[h=2]Coming up...[/h]U.S. inflation data for June at 8:30 a.m. is expected to show prices ticked higher in the month. Fed Governor Lael Brainard, Atlanta Fed President Raphael Bostic, St. Louis Fed President James Bullard and Philadelphia Fed President Patrick Harker all speak this afternoon. OPEC's monthly oil-market report is due as demand concerns for the commodity rise again.
[h=2]What we've been reading[/h]This is what's caught our eye over the last 24 hours.

[h=2]And finally, here’s what Joe's interested in this morning[/h]I would never call Tesla a bubble, because that's not my job, and making such calls are incredibly risky and almost never turn out well. That being said, if you do think that Tesla is in a bubble, here's something for your argument. Remember back in late 2017, when the Bitcoin bubble peaked and burst (you can easily call them in retrospect), one of the things we saw was the explosion of alternative coins to satisfy the overwhelming demand for cryptocurrencies. Bitcoin's supply is, of course, fixed, but that didn't stop the industry from pumping and hyping dozens of others coins onto fresh retail money. On December 19, 2017 the popular exchange Coinbase announced it was listing something called Bitcoin Cash which was a fork of Bitcoin itself. Then for one brief moment, the largest holder of the cryptocurrency XRP became wealthier than Mark Zuckerberg. At the same time, the media was introducing the world to coins like Stellar and Cardano.
All this stuff proceeded to collapse massively in the years ahead, as the manufacture of new financial assets more than satisfied the demand to own them. That's one way bubbles die. The industry just churns out more and more of what people want, whether it's cryptos, Beanie Babies, or safe assets tied to U.S. housing.
1400x-1.jpg


Anyway, you could argue that we're in a similar stage with electric cars. There was a point where you could say that Tesla was the only game in town if you really wanted to bet on the industry. But not anymore. Now there's Nikola. And Fisker. And Workhorse. And don't forget about Nio. Oh and Hyliion. The list goes on and on, and it can keep going on as long as speculators are able to bring SPACs to the market, with the intention of buying EV companies.

In a 2017 academic paper called Bubbles for Fama, the economists Robin Greenwood, Andrei Shleifer, and Yang You identified several characteristics of stock bubbles, including extremely sharp price increases, new stock issuance, and investor preference for newer and younger firms. The paper is worth a read when trying to assess this or any other market.

Joe Weisenthal is an editor at Bloomberg.
Like Bloomberg's Five Things? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close.



 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens


new-jt-banner-newsletter.png

Global Market Comments
July 14, 2020
Fiat Lux

Featured Trade:
(UPDATE ON THE COVID-19 VACCINE FRONTRUNNER)
(AZN), (MRNA), (RHHBY), (LLY), (PFE), (JNJ)

mti-pos-53.jpg



Update on the Covid-19 Vaccine Frontrunner

With the flu season just around the corner and herd immunity nowhere in sight, the pressure to develop a COVID-19 vaccine becomes even more urgent. From where things stand right now though, it looks like we could have a vaccine either already available on the market or ready to hit the market around this time in 2021.We know we’ll need hundreds of millions of vaccine doses, and the majority of the vaccine programs today are getting built on industrial-scale vaccine platforms. This is positive news.On an even more positive update, a handful of biotechnology and health care companies are now on late-stage testing for the COVID-19 vaccine.Leading the charge so far is AstraZeneca (AZN), which received $1.2 billion in financial assistance courtesy of the US government’s Operation Warp Speed program.AstraZeneca is working on an experimental vaccine, called AZD1222, with the University of Oxford and China National Pharmaceutical Group (Sinopharm).So far, this is the only COVID-19 vaccine candidate in late-stage Phase 3 trials.The trials are scheduled to be conducted in different countries, with some already in progress in South Africa, Brazil, and of course, the UK.The stage will enroll over 10,000 people in the UK alone. The goal is to determine AZD1222’s efficacy in a sizeable group aged 18 and older.What we know about AstraZeneca’s vaccine candidate is that it’s created from a weakened version of adenovirus, which comes from one of the virus types that causes the common cold. It also includes genetic material from COVID-19, which was added to help the patient’s body recognize the pathogen and trigger a defense mechanism to fight off the infection.Researchers say that the best-case scenario is for the Phase 3 efficacy results of the AstraZeneca vaccine to be available by this fall.However, AstraZeneca remains an attractive stock even sans its Covid-19 program thanks to its remarkable drug pipeline. With the foresight to stockpile drugs during this pandemic, the company’s earnings are projected to continuously grow.In the past five to six years, AstraZeneca has been aggressive in investing in its pipeline to combat patent losses. Now, the company joins Roche (RHHBY) and Eli Lilly (LLY) in the list of companies with the most innovative candidates that are poised to launch commercial products capable of driving growth in the next decade.A notable growth driver for AstraZeneca is its cancer franchise, particularly its key drug Tagrisso, which is set to tap into a massive market.Before AstraZeneca was dubbed the leader in the COVID-19 vaccine race, there was Moderna (MRNA). Actually, this small biotechnology company is also expected to begin its late-stage Phase 3 trial in July.Like AstraZeneca, Moderna is also one of the companies included in the Operation Warp Speed project and received $483 million from the government.Unlike AstraZeneca, Moderna appears to be experiencing delays due to conflicts between the company’s experts and the US government scientists.While Moderna shares jumped by over 200% since the pandemic started, these reported tensions represent a risk for its investors. It is particularly alarming because the company is a clinical-stage biotechnology company with no marketed products.Although Moderna’s timeline remains to be the most aggressive, it could easily drown in the competition.Keep in mind that other companies competing for the top spot in the COVID-19 race are all established and armed with extensive experience in launching new drugs to market. The list includes Pfizer (PFE), which has a market capitalization of $185.86 billion, and Johnson & Johnson (JNJ) with $375.40 billion. Needless to say, the inexperience of companies like Moderna could prove to be a handicap in this highly competitive race.
azn-jul14.png

azn-logo.png



Quote of the Day

“The rule book on how things are done and how they will play out you can just throw away right now,” said Scott Minerd of Guggenheim Partners.
rule-book.png






 

Member
Handicapper
Joined
Sep 25, 2005
Messages
4,522
Tokens
Joe Biden calls for $2 trillion in spending on clean energy. are you fucking kidding me , They are starting UBI and he thinks there will be 2 trillion.
 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
Without JPM reporting decent numbers this AM might have looked different early...
 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens


July 15, 2020
Good morning. A reminder to sign up for tomorrow’s DealBook Debrief call about “Trump’s Covid calculus” with The Times’s White House correspondent Maggie Haberman. It starts at 11 a.m. Eastern and you can R.S.V.P. here. (Was this email forwarded to you? Sign up here.)

merlin_171572538_1b7642a5-e948-489e-9648-f8e2dce20005-articleLarge.jpg
Jamie Dimon of JPMorgan Chase Jim Watson/Agence France-Presse — Getty Images
‘It’s just very peculiar times’
Three of America’s six biggest banks released second-quarter earnings yesterday. The others report today and tomorrow. Based on the first batch of results, there’s trouble ahead.
Citigroup, JPMorgan Chase and Wells Fargo set aside $28 billion for loan-loss provisions, on top of $19 billion earlier this year. That pummeled second-quarter profits, which were collectively down more than 80 percent versus the same time last year. There could be some “kitchen sinking” — that is, dumping all the bad news into one quarter so future periods look better by comparison. Even so, there was little to be hopeful about.
15db-newsletterbanks-articleLarge.png
It could get worse before it gets better. Jamie Dimon of JPMorgan said that unprecedented economic stimulus measures had delayed the effects he’d expect in a “normal recession,” like falling incomes, savings and property prices. “It’s just very peculiar times,” he told analysts on a conference call. If the economy picks up before stimulus programs expire, the banks’ loss provisions could be excessive. But that’s not what executives seemed to suggest:
• “May and June will prove to be the easy bumps in terms of this recovery. And now we’re really hitting the moment of truth, I think, in the months ahead.” — Jennifer Piepszak, JPMorgan’s C.F.O.
• “Our view of the length and severity of the economic downturn has deteriorated considerably from the assumptions used last quarter.” — Charlie Scharf, Wells Fargo’s C.E.O.
• “I don’t think anybody should leave any bank earnings call this quarter simply feeling like the worst is absolutely behind us and it’s a rosy path ahead.” — Mike Corbat, Citigroup’s C.E.O.
It’s not all bad. Trading and underwriting revenue surged, helping JPMorgan and Citi offset the gloom elsewhere. Retail-focused Wells Fargo wasn’t as lucky, recording its first quarterly loss in more than a decade. That could be particularly promising for Goldman Sachs, which reports today, and Morgan Stanley, which is up tomorrow. But ominously, lenders increased loss provisions for business loans more in percentage terms than they did for consumer debt, suggesting that they expect more corporate bankruptcies. (The Fed governor Lael Brainard warned as much yesterday).
Fun fact: Who needs cash when you’re stuck at home? Wells Fargo said that A.T.M. transactions were down 28 percent from a year ago, but the average withdrawal per visit was higher.
____________________________
Today’s DealBook Briefing was written by Andrew Ross Sorkin in Connecticut and Michael J. de la Merced and Jason Karaian in London.
____________________________
merlin_174579009_cebd84c9-7de8-40cf-9d26-7531421b339d-articleLarge.jpg
Mark Lennihan/Associated Press
Apple wins big over back taxes
A European court sided with the iPhone maker today, potentially saving it a $15 billion tax bill. The court ruled that the E.U. competition authority failed to show that Ireland had unfairly given Apple low taxes.
It’s a big loss for Margrethe Vestager, the E.U. competition chief. She has regularly targeted such arrangements, angering tech executives like Tim Cook of Apple, who derided the campaign as “total political crap.” (Even so, the bill would have amounted to a bit more than the tech giant earns in a quarter.)
The same court overturned a similar demand involving Starbucks last year. The directorate Ms. Vestager runs “did not succeed in showing to the requisite legal standard that there was an advantage,” the court ruled. Expect Ms. Vestager to appeal the decision.
merlin_174360000_9eb90326-a4c5-429a-8da4-7479fcf078f1-articleLarge.jpg
Harvard’s campus Maddie Meyer/Getty Images
Trump’s U-turn on student visas
After opposition from universities, Silicon Valley and 20 states, President Trump backed off a hard-line immigration proposal.
The White House abandoned a policy that would have stripped international students of their visas if they did not attend some classes in person. “If they’re not going to be a student or they’re going to be 100 percent online, then they don’t have a basis to be here,” Ken Cuccinelli, the acting deputy secretary of homeland security, said this month.
The rules could have led to a huge loss in international students, a valuable source of income for schools and skilled workers for American businesses, particularly tech companies. The Times notes that the one million foreign students who enroll at U.S. schools each year contribute $41 billion to the economy and support more than 458,000 jobs.
Universities sued to challenge the policy, led by Harvard and M.I.T., which argued that it was an effort to force schools to reopen. The pressure grew when tech giants like Facebook and Google joined in. Then, 15 Republican lawmakers urged the White House to reverse course.
But damage has been done, The Washington Post columnist Catherine Rampell argues. Other immigration hurdles — including delays in visa processing and travel bans — will most likely contribute to a huge drop in international student enrollment this fall. (How steep? Between 63 percent and 98 percent, according to a new analysis.)
Here’s what else is happening
Moderna’s Covid-19 vaccine showed promise in a clinical trial. The vaccine, the first to be tested on humans, provoked a notable immune response and appeared safe for the first 45 people to receive it, researchers wrote in the New England Journal of Medicine. It is to move to Phase 3 trials this month.
President Trump signed a Hong Kong sanctions bill. The new law gives him additional power to punish Chinese officials over a security act that gives Beijing more control over the territory. (Separately, The Times said it would move part of its Hong Kong news operation to Seoul, South Korea, because of concerns over the law.)
A federal judge scuttled Harvey Weinstein’s civil settlement. Judge Alvin Hellerstein of the Southern District of New York picked apart the $25 million proposal, questioning its overall fairness and suggesting that the agreement was misconceived.
Delta said its comeback had stalled. The U.S. airline reported a $5.7 billion lossfor its latest quarter and said it would scale back its flight schedule.
The N.F.L. has no plan for its upcoming season. Training camps are scheduled to start July 28, but the league has yet to figure out social distancing guidelines or the logistics that other leagues developed as part of their restarts.
merlin_174525780_d0010ab8-9bc2-4660-aacd-ceeacc1a9d6c-articleLarge.jpg
Huawei’s office in Reading, England. Daniel Leal-Olivas/Agence France-Presse — Getty Images
America’s fight with Huawei goes global
Britain, reversing course, said yesterday that it would strip Huawei technologyfrom its 5G wireless network. President Trump claimed a victory in his battle against the Chinese tech giant.
Prime Minister Boris Johnson bowed to political pressure, after saying Huawei products could be used in Britain’s networks on a limited basis. Huawei equipment purchases will be banned from December, and existing gear will be removed by 2027.
• British critics, including in its national security agencies, worry that Huawei products could be used to spy for Beijing. The company strongly denies those allegations.
Mr. Trump celebrated the announcement. “We convinced many countries, and I did this myself for the most part, not to use Huawei, because we think it’s an unsafe security risk,” he said at a news conference.
The move ends a relationship that began in 2005. Britain was the first European country to let Huawei sell products to its companies. Just last month, the Chinese company agreed to fund a $1.25 billion research center at Cambridge. And John Browne, the former BP chief and an elder statesman of British business, served as chairman of Huawei’s U.K. board — though he will now step down.
Britain faces potentially big consequences. It may have repaired strains in its relationship with the U.S., but the ban will add costs and delays to its 5G rollout. And Beijing threatened that Britain would “bear the consequences” of treating China with hostility.
The most crowded trade in history
For the past 25 years, Bank of America has surveyed fund managers about how they are positioning portfolios. When a consensus emerges, the bank’s pollsters say, investors generally profit by betting against it.
Buying tech stocks is now the “longest ‘long’ of all-time,” the latest survey found. Nearly three-quarters of fund managers agreed that holding big U.S. tech stocks was the “most crowded” trade in the market, the survey’s strongest ever consensus. For contrarians, that’s a sign that it’s time to sell, Bank of America says.
Tech giants’ dominance is a risk to long-term returns, Goldman Sachs analysts write in a new research note. The five largest stocks in the S&P 500 index — Alphabet, Amazon, Apple, Facebook and Microsoft — now account for 23 percent of its market cap. “We believe further equity upside would require participation from a broader subset” of the index, the analysts say. (For what it’s worth, Goldman concludes that the S&P 500 will generate a 6 percent annual return over the next decade, versus nearly 14 percent over the past decade and 10 percent since 1960.)
The speed read
Deals
• Google agreed to invest $4.5 billion in Jio, the digital services arm of India’s Reliance Industries, joining the likes of Facebook and Silver Lake. (Bloomberg)
• Virgin Atlantic secured a $1.5 billion financial lifeline, made up of cash and concessions from partners like payments processors. (NYT)
• Electric-car makers like Fisker and Rivian are raising billions without having sold a single vehicle. (Axios)
Politics and policy
• Joe Biden unveiled a $2 trillion climate plan focused on expanding green energy as a way to bolster the economy. (NYT)
• The lobbyist Jack Abramoff pleaded guilty to illegally promoting a cryptocurrency. (Bloomberg)
Tech
• A German court ruled that Tesla had exaggerated promises about the capabilities of its autonomous vehicle technology. (NYT)
• Google reportedly prioritized YouTube in video search results to give it more leverage in negotiations with content providers. (WSJ)
Best of the rest
• BlackRock said that it recently voted against directors at 53 companies for failing to prepare for climate change, and threatened the same for 191 more. (Bloomberg)
• Many U.S. retailers have ended “hero” bonuses for essential workers, despite a surge in coronavirus cases. (NYT)
Thanks for reading! We’ll see you tomorrow.




 

Forum statistics

Threads
1,120,307
Messages
13,580,051
Members
100,958
Latest member
onestpfwdtwostpsback
The RX is the sports betting industry's leading information portal for bonuses, picks, and sportsbook reviews. Find the best deals offered by a sportsbook in your state and browse our free picks section.FacebookTwitterInstagramContact Usforum@therx.com